Lysophosphatidic acid receptor antagonist

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lysophosphatidic acid receptor antagonist, covering 2019-05-22 to 2019-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis [Phase 2]